Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Zai Lab (ZLAB) EBT (2018 - 2025)

Historic EBT for Zai Lab (ZLAB) over the last 8 years, with Q3 2025 value amounting to -$36.0 million.

  • Zai Lab's EBT rose 1369.78% to -$36.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$206.8 million, marking a year-over-year increase of 2364.28%. This contributed to the annual value of -$257.1 million for FY2024, which is 2316.57% up from last year.
  • Zai Lab's EBT amounted to -$36.0 million in Q3 2025, which was up 1369.78% from -$40.7 million recorded in Q2 2025.
  • In the past 5 years, Zai Lab's EBT ranged from a high of -$36.0 million in Q3 2025 and a low of -$233.1 million during Q1 2021
  • In the last 5 years, Zai Lab's EBT had a median value of -$81.7 million in 2024 and averaged -$98.1 million.
  • In the last 5 years, Zai Lab's EBT plummeted by 38714.76% in 2021 and then soared by 7076.94% in 2022.
  • Quarter analysis of 5 years shows Zai Lab's EBT stood at -$211.3 million in 2021, then surged by 70.77% to -$61.8 million in 2022, then crashed by 54.49% to -$95.4 million in 2023, then increased by 14.4% to -$81.7 million in 2024, then soared by 55.97% to -$36.0 million in 2025.
  • Its EBT stands at -$36.0 million for Q3 2025, versus -$40.7 million for Q2 2025 and -$48.4 million for Q1 2025.